GCP
BHVN

GSA Capital Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

GSA Capital Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,122
Closed -$321K – 2050
2022
Q3 		$321K Buy
+2,122
New +$321K 0.04% 889